| Literature DB >> 6827556 |
J B Bicking, M G Bock, E J Cragoe, R M DiPardo, N P Gould, W J Holtz, T J Lee, C M Robb, R L Smith, J P Springer, E H Blaine.
Abstract
Chain modification of a thiazolidinone prostaglandin isostere has led to the production of 4-[3-[3-[2-(1-hydroxycyclohexyl)ethyl]-4-oxo-2-thiazolidinyl]propyl] benzoic acid (5b) which at 1 mg/kg po in the conscious dog causes a 70% increase in renal blood flow over control values with a duration of action exceeding 5 h. Preliminary testing indicates that 5b has a relatively specific action on the vasculature of the kidney. The enantiomers of 5b have been separated and the renal vasodilatory activity has been found to be entirely a property of the R-(+) enantiomer.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6827556 DOI: 10.1021/jm00357a006
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446